Johnson & Johnson Introduces Pulsed Field Ablation Technology in Peru to Advance Atrial Fibrillation Treatment

-Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atri...

March 17, 2026 | Tuesday | News
Philips Expands Digital Pathology Portfolio with Cloud-Enabled IntelliSite Solution on HealthSuite

Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Royal Philips (NYSE: PHG, AEX: ...

March 13, 2026 | Friday | News
Allosteric Bioscience Advances Integrated Platform To Decode And Control Molecular Drivers Of Aging

Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular ...

March 06, 2026 | Friday | News
Codexis, Inc. Advances RNA Manufacturing with 50g siRNA Production Agreement for Cardiovascular Program

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing,  announced it has ent...

March 06, 2026 | Friday | News
AN2 Therapeutics, Inc. Advances Oral Epetraborole into Phase 2 for Polycythemia Vera

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron che...

March 05, 2026 | Thursday | News
Innovent Biologics, Inc. Announces NMPA Approval of Jaypirca® for CLL/SLL in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

March 03, 2026 | Tuesday | News
SciBase Holding AB Secures FDA Label Expansion to Broaden Clinical Use of Nevisense in U.S. Dermatology Practices

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that it has received appro...

March 03, 2026 | Tuesday | News
Illumina, Inc. Showcases Oncology Breakthroughs Powered by Integrated Multiomics Platform

Illumina, Inc. announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technolo...

February 27, 2026 | Friday | News
Mahzi Doses First Patient in Phase 1/2 Trial of MZ-1866, the First Investigational Gene Therapy for Pitt Hopkins Syndrome

First Investigational Gene Therapy for Pitt Hopkins Syndrome Intended to Address Underlying Disease Biology -- Mahzi Therapeutics Inc., a clinical...

February 27, 2026 | Friday | News
PacBio and DNAstack Unite to Accelerate Rare Disease Discovery Through Federated HiFi Sequencing

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies,  announced a collaboration with DNAstack to power the wor...

February 26, 2026 | Thursday | News
IDT Launches Next-Generation Sequencing Innovations To Streamline Cancer Genomics Workflows

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flex...

February 25, 2026 | Wednesday | News
DeciBio Consulting LLC Launches EU-5 Oncology Genomics Tracker, Revealing Adoption Trends and Precision Medicine Gaps

A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides update...

February 18, 2026 | Wednesday | Reports
MEDIPOST Inc. Files IND Amendment to Advance Phase III Stem Cell Therapy Trial for Knee Osteoarthritis

MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative disea...

February 16, 2026 | Monday | News
Alto Neuroscience, Inc. Completes Patient Enrollment in Phase 2 Trial of ALTO-101 for Schizophrenia-Related Cognitive Impairment

-Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medi...

February 16, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close